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ABSTRACT
Background. Intellectual disability (ID) is highly prevalent in tuberous sclerosis (TS). Putative
neurobiological risk factors include indices of cortical tuber (CT) load and epilepsy. We have used
univariate and multivariate analyses, including both CT and epilepsy measures as predictors, in an
attempt to clarify the pattern of cross-sectional associations between these variables and ID in TS.
Method. Forty-eight children, adolescents and young adults with TS were identiﬁed through re-
gional specialist clinics. All subjects underwent thorough history taking and examination, and had
brain magnetic resonance imaging (MRI) scans. The number and regional distribution of CTs was
recorded. Subjects were assigned to one of nine ordered intellectual quotient (IQ) categories (range
<25 to>130) using age-appropriate tests of intelligence.
Results. On univariate analyses, ID was signiﬁcantly associated with both a history of infantile
spasm (IS) (Z=x2.49, p=0.01) and total CT count (Spearman’s r=x0.30, p=0.04). When con-
trolling for total CT count, the presence of CTs in frontal (regression coeﬃcient=x2.43, p=0.02)
and temporal (regression coeﬃcient=x1.60, p=0.02) lobes was signiﬁcantly associated with ID. In
multivariate analyses the association between IS and ID was rendered insigniﬁcant by the inclusion
of the presence of CTs in temporal and frontal lobes, both of which remained associated (p=0.05
and p=0.06 respectively) with ID.
Conclusions. The presence of CTs in speciﬁc brain regions as opposed to a history of IS was
associated with ID in TS. The signiﬁcance of these ﬁndings is discussed in relation to previous work
in TS, and the neural basis of intelligence.
INTRODUCTION
Tuberous sclerosis (TS) is a multisystem genetic
disorder with a prevalence of approximately
10/100 000 (O’Callaghan et al. 1998). TS is
characterized by hamartomatous growths in
multiple organs including the brain, skin, eyes,
heart, lungs, and kidneys (Roach et al. 1998;
Roach & Sparagana, 2004). The central nervous
system (CNS) lesions in TS are associated with
a range of neurodevelopmental problems that
can give rise to substantial morbidity. Such
neurodevelopmental problems include intellec-
tual disability (ID), speciﬁc learning disabilities,
epilepsies [in particular, infantile spasm (IS)]
and autism spectrum disorders (ASD) (Asato &
Hardan, 2004). Individuals with TS also show
elevated rates of emotional and behavioural
problems in both childhood and adulthood
(Lewis et al. 2004; Raznahan et al. 2006),
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although the brain–behaviour links for these
latter disorders are poorly understood. Some
groups, however, have begun to examine brain
mechanisms that might account for the well-
documented elevated risk of ASD in TS (Bolton
et al. 2002).
Mutations in one of two genes give rise to TS:
the TSC1 gene located at 9q34 (van Slegtenhorst
et al. 1997) and the TSC2 gene located at
16p13.3 (The European Chromosome 16 Tuber-
ous Sclerosis Consortium, 1993). Approxi-
mately two-thirds of cases are due to new
mutations, while the rest are inherited in an
autosomal dominant fashion. The gene pro-
ducts of TSC1 (hamartin) and TSC2 (tuberin)
form a complex that operates in the insulin
signalling pathway to regulate cell division, and
hence they function as tumour suppressors.
The molecular mechanisms linking abnormali-
ties of hamartin and tuberin function to the
hamartomatous growths seen in TS are being
increasingly well understood (Jozwiak, 2006).
The ‘two-hit ’ model for loss of heterozygosity
(Knudson, 1971) accounts well for the varia-
bility in expressivity, and is generally supported
by histochemical studies of non-CNS hamar-
tomas in TS (Henske et al. 1996). The suitability
of this model to explain CNS hamartomas is
not yet clear (Jozwiak & Jozwiak, 2005).
The classical CNS lesions in TS are corti-
cal tubers (CTs) and subependymal nodules
(SENs). SENs can undergo neoplastic change to
subependymal giant cell astrocytomas (Goh
et al. 2004). CTs have been reported in 82–
100% of TS suﬀerers, and SENs in 64–100%
(Ridler et al. 2004). Besides these focal lesions,
less discreet dysplasias such as transmantle
cortical dysplasia and hemimegalencephaly are
seen in TS. More recently, neuroradiologically
deﬁned white matter linear migrational streaks
and histologically identiﬁed heterotopic neuro-
nal aggregates and disrupted cortical architec-
ture have highlighted the importance of viewing
TS, at least in part, as a neuromigrational
disorder (Vinters et al. 1998). A recent magnetic
resonance imaging (MRI) study using whole-
brain computer-assisted morphometry techni-
ques for image analysis revealed widespread
grey and white matter deﬁcits in individuals
with TS when compared to neurotypicals
(Ridler et al. 2001). Intriguingly, some of these
deﬁcits have been shown to correlate positively
with the degree of memory impairment in
this sample (Ridler et al. 2007). This ﬁnding
has implications for our causal models of neuro-
psychiatric impairment in TS.
The neurodevelopmental outcome of interest
in our study is ID. Rates of ID seen in TS have
varied among studies, ranging between 80%
(Hunt, 1993) and 44% (Joinson et al. 2003). The
study by Joinson et al. used an epidemiological
sample and measured intellectual function using
standardized tests. A bi-modal distribution of
intellectual quotient (IQ) was found in TS.
Speciﬁc cognitive deﬁcits have also been re-
ported in individuals without ID (Harrison et al.
1999; De Vries & Bolton, 1999).
How are the brain abnormalities in TS related
to epilepsy and ID? Associations have been re-
ported between the total number of CTs and
both ID (not always quantiﬁed by standardized
methods) (Roach et al. 1987; Shepherd et al.
1995; Goodman et al. 1997; Weber et al. 2000;
Bolton et al. 2002; O’Callaghan et al. 2004) and
varying facets of epilepsy (seizure type, age
of seizure onset or quality of seizure control)
(Doherty et al. 1920; Roach et al. 1987;
Shepherd et al. 1995; Goodman et al. 1997;
O’Callaghan et al. 2004; Wong & Khong, 2006).
Evidence for a similar relationship between
neurological outcome and SENs is, however,
conﬂicting (Menor et al. 1992; Hosoya et al.
1999).
The prevalence of seizures in TS has varied
between studies, from 88% in clinic samples
(Gomez, 1979) to around 78% in population
samples (Webb et al. 1996; Joinson et al. 2003).
Almost all individuals with ID in TS have a
history of epilepsy. IS is the most common
seizure type overall (Jambaque et al. 1991).
Although sample ascertainment and methods of
measuring intellectual function vary widely,
several groups have shown that epilepsy (and IS
in particular) shows strong statistical associ-
ations with ID in TS (Riikonen & Simell, 1990;
Shepherd & Stephenson, 1992; Hunt, 1993;
Shepherd et al. 1995; Webb et al. 1996; Jozwiak
et al. 1998; Joinson et al. 2003; Humphrey et al.
2004; O’Callaghan et al. 2004). The most recent
of these studies, which used a retrospective co-
hort design in a large, well-characterized group
of both children and adults, also found evidence
that the duration of untreated IS and the quality
of control of seizures after IS cessation were
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correlated with IQ. It is important to note,
however, that the relationship between IS and
ID is not deterministic, and causality has not
been established.
It is clear, then, that when attempting to bet-
ter understand the potential neurobiological
causes for ID in TS, research must be carried
out in a manner that enables epilepsy (IS in
particular) and brain lesions (deﬁnitely CTs and
possibly SENs) to be treated as separate risks,
while allowing for their inter-relationship. To
our knowledge, only one publication has done
so (O’Callaghan et al. 2004).
O’Callaghan et al. (2004) explored the re-
lationship between CT count, IS history and IQ
in 41 children and adults with TS. These subjects
were drawn from a larger epidemiological sam-
ple of 179 cases with TS (O’Callaghan et al.
1998). The 41 subjects studied had an average
IQ of 91 (range 52–130). Sixty-three per cent
had a history of epilepsy, and 25% had a history
of infantile spasms. Whole-brain and lobar CT
numbers were rated by a neuroradiologist fol-
lowing standardized MR imaging, and IQ was
measured by one of three diﬀerent instruments:
the Weschler Adult Intelligence Scale (WAIS-
R), the Weschler Scale for Children (WISC-III)
and Raven’s Coloured Progressive Martrices.
Seizure history was determined by history from
subjects and informants, and by case-note re-
view. The sole variable relating to seizures used
in analyses was the dichotomous one of IS
present/IS absent. Signiﬁcant associations were
reported between both whole-brain CT count
and IS status, and IQ. Total CT count was also
associated with IS status. Multivariate analyses
showed that increasing total CT count and
positive IS status were both independently as-
sociated with lowered IQ. These factors in
combination accounted for 47% of the variance
in IQ scores. When the relationships between
lobar CT counts and IQ were considered using
forward stepwise multiple linear regression, only
occipital lobe CT count was associated with
IQ. This ﬁnding is surprising as most evidence
suggests that performance on tests of intel-
ligencewould be dependent on intact frontal lobe
function (Duncan, 2005; Toga & Thompson,
2005). While attempting to better under-
stand the roots of ID in TS, it is important to
acknowledge the large amount of literature
on the spatial distribution of neural systems
underpinning performance on tests of intel-
ligence in neurotypicals across development, a
theme that we develop in our discussion later.
We hypothesized that whole-brain CT count,
the presence of IS, and the age of IS onset would
signiﬁcantly inﬂuence IQ. We predicted that
the inﬂuences of each individual factor would
remain signiﬁcant after multivariate analysis,
and that of all lobes, frontal lobe CT status
would best account for the observed variation
in IQ.
METHOD
Subjects
Full details of sample ascertainment and charac-
terization can be found in Bolton et al. (2002).
Seventy-two subjects with TS were identiﬁed
through a series of consecutive referrals to a
specialist clinic at Addenbrooke’s NHS Trust,
Cambridge, UK (n=19), and an epidemiologi-
cal study of children with TS in eastern UK
(n=53). All subjects met the criteria for TS di-
agnosis as deﬁned by Roach et al. (1998). Brain
MRI scans were obtained from 48 of these 70
subjects. Compared to the 22 subjects for whom
brain MRI scans were not available, subjects
with MRI data did not have signiﬁcantly dif-
ferent sex (x2=1.81, p=0.180) or age (F=0.07,
p=0.88) distributions. Our subsample did,
however, have signiﬁcantly lower IQ (Z=3.32,
p=0.001). Complete MRI and seizure data were
available on 47 subjects.
Assessment
Psychometric intelligence
Intellectual ability was measured on an ordered
categorical scale. This scale consisted of eight
consecutive IQ ‘bins’ with equal ranges.
Allocation of each subject to one of these IQ
categories was determined by experienced clin-
icians who reviewed the results of all tests of
cognitive ability and adaptive behaviour avail-
able for each subject. The tests varied across
subjects according to their age and/or cognitive
ability. Cognitive tests included Mullens scales,
Weschler scales, Raven’s Coloured Matrices
and the British Picture Vocabulary Test. Adapt-
ive function was assessed using the Vineland
Adaptive Behaviour Scales (VABS), or from
previous clinical evaluations when VABS scores
were not available.
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Epilepsy and IS history
Seizure history was determined through a stan-
dardized parental history and from review of
contemporaneous clinical records. A consensus
best-estimate method was used in any instance
where there was disagreement between the two
sources of information. IS history was rated as
absent, probably present, and deﬁnitely present.
These latter two categories were collapsed to
yield a binary variable of IS present/absent.
Thus, the key variables considered in this study
are the presence or absence of epilepsy, the
presence or absence IS and, where relevant, the
age of IS onset. Agreement between the two
sources of data used was excellent for both IS
presence and age of IS onset (k=0.8 and
Spearman’s r=0.79 respectively).
Cortical tubers
Brain MRI scans that had been acquired pre-
viously for clinical purposes were used where
available. Where not already available, MRI
scans were acquired on a 1.5 T superconduct-
ing system (Signa, General Electric Medical
Systems, Milwaukee, WI, USA) using standard
dual-echo/fast spin–echo and fast FLAIR se-
quences. In all cases CT presence and location
were determined by two radiologists (P.D.G.
and N.H.) who independently rated scans while
blind to clinical details, with reference to a pre-
speciﬁed coding scheme based on a detailed at-
las (Duvernoy, 1999). Inter-rater agreement was
excellent : for total CT count, k=0.93; temporal
lobe involvement, k=0.81; and temporal lobe
CT count, k=0.90. The variables used to reﬂect
CT load and location were continuous variables
(total cerebral CT count and individual lobar
CT counts) and dichotomous variables (any
tubers in a given lobe or not).
Data analysis
All analyses were conducted using SPSS version
12.0.1 (SPSS Inc., Chicago, IL, USA). All uni-
variate analyses and multivariate analyses lim-
ited to CT variables as predictors were carried
out using the complete dataset of 48 subjects.
Multivariate analyses including CT and IS as
predictors were carried out using 47 subjects
who had complete IS and CT data.
As our IQ was measured as an ordered
categorical variable, all univariate analyses were
conducted using non-parametric techniques.
Multivariate analyses were carried out using
ordinal logistical regression, with a logit link
function.
The relationships between variables of in-
terest were also explored while treating psycho-
metric intelligence as a dichotomous variable
(ID or no ID). As the pattern of associations
found in these analyses fully supported those
revealed by the techniques above, we limit our-
selves to reporting the results of analyses treat-
ing IQ as an ordered categorical variable, as this
scale of measurement better approximates the
underlying distribution of IQ.
RESULTS
Sample characteristics (refer to Table 1)
Demographics
The total sample of 48 individuals included 17
(35.4%) females. The sample ranged in age
from 2 years 6 months to 25 years, with a mean
age of 10 years 3 months.
IQ
IQ in our sample ranged from <25 to >130.
The median IQ band was 55–69. The ordered
categories reﬂecting IQ distribution appeared
normal on visual inspection (see Fig. 1a) and
passed a Shapiro–Wilk test of normality (Z=
0.12, p=0.07). Twenty-nine (60.4%) of our
sample had ID, that is an IQ<70.
Epilepsy and IS
Of the 47 individuals for whom epilepsy history
was available, 43 (91.5%) had a positive history.
Of these, 19 (44.2%) had a positive history of
infantile spasms. The average age of IS onset
was 6 months.
Cortical tubers
Total CT count ranged between 1 and 29. Mean
total CT count was 11. This continuous variable
appeared to be non-normally distributed on in-
spection, and a Shapiro–Wilk test for normality
(p=0.018) supported this impression. With re-
gard to the frequency of aﬀected lobes (left and/
or right), the frontal lobes were most commonly
aﬀected (89.6%), followed by parietal (83.3%),
occipital (64.6%), temporal (62.5%) and cer-
ebellar (8.3%) lobes. There were no signiﬁcant
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laterality eﬀects in lobar tuber number for all
lobes where this statistic was available (frontal,
parietal, occipital, temporal). A Friedman test
revealed signiﬁcant diﬀerences in lobar (left and
right counts combined) CT counts (x2=49.1,
p<0.0001). Post-hoc analyses using the
Wilcoxon signed ranks test found that total
frontal lobe CT count was signiﬁcantly greater
than that for all other lobes. All other inter-
lobar comparisons failed to reach signiﬁcance.
The presence of frontal (Z=3.64, p<0.001),
temporal (Z=4.03, p<0.001) and occipital
(Z=4.42, p<0.001) CTs was associated with
higher total CT count. Lobar CT counts were all
highly correlated with total CT count.
Relationships between measures of epilepsy,
IS, CT and IQ considered in isolation from
each other
Epilepsy, IS and IQ
A history of epilepsy was not signiﬁcantly as-
sociated with IQ (p=0.08). However, as il-
lustrated in Fig. 1b, a history of IS was
signiﬁcantly associated with IQ (Z=x2.49,
p=0.013), and this remained true in an analysis
restricted to those 43 subjects with a history
of epilepsy (Z=x2.11, p=0.035). No statisti-
cally signiﬁcant relationship was found, how-
ever, between the age of onset of IS and IQ
(Spearman’s r=0.25, p=0.30).
Epilepsy, IS and CTs
A history of epilepsy was strongly associated
with total CT number (Z=x2.92, p=0.003).
The presence of CTs in frontal (Fisher’s exact
p=0.002) and occipital (Fisher’s exact p=0.01)
lobes was associated with a history of epilepsy.
Furthermore, CT counts in frontal (Z=x2.81,
p=0.005) and occipital (Z=x2.43, p=0.015)
lobes were signiﬁcantly higher in those with a
history of epilepsy.
We next determined whether, among those
subjects with a history of epilepsy (n=43), IS
status showed any association with CT vari-
ables. Those subjects with a history of IS did not
have signiﬁcantly more cerebral CTs (p=0.27).
There were no cerebral lobes for which the
presence or number of CTs was associated with
IS. No signiﬁcant relationship was found be-
tween IS age of onset and total CT count
(Spearman’s r=0.01, p=0.76).
CTs and IQ
A signiﬁcant negative correlation was found
between total CT count and IQ (Spearman’s
r=x0.3, p=0.04). As shown in Fig. 1c and 1d,
the presence of tubers in frontal (Z=x2.71,
p=0.007) and temporal (Z=x2.82, p=0.005)
lobes was associated with lowered IQ. Similar
associations were not found for cerebellar (p=
0.07), parietal (p=0.79) or occipital (p=0.06)
lobes. Unfortunately, sample sizes were too
small to allow us to meaningfully explore
Table 1. Sample characteristics (maximum
n=48)
Character n (%)/mean (S.D.)
Demographics
Female 17 (35.4)
Age in months (n=41) 123.63 (55.22)
Intellectual status
Presence of ID
IQ<70 29 (60.4)
IQo70 19 (39.6)
IQ band frequencies
<25 5 (10.4)
25–39 4 (8.3)
40–54 9 (18.8)
55–69 11 (22.9)
70–84 8 (16.7)
85–99 8 (16.7)
100–114 2 (4.2)
114–130 0
o130 1 (2.1)
Cortical tuber characteristics
Tuber counts
Total cerebral 11.04 (7.71)
Frontal lobes 5.42 (4.05)
Parietal lobes 1.18 (1.59)
Temporal lobes 1.98 (2.12)
Occipital lobes 1.88 (1.94)
Number of subjects with aﬀected lobes
Any cerebral 48 (100)
Frontal 43 (89.6)
Parietal 40 (83.3)
Occipital 31 (64.6)
Temporal 30 (62.5)
Cerebellar 4 (8.3)
Epilepsy characteristics
History of epilepsy
Data missing 1 (2.1)
Negative 4 (8.3)
Positive 43 (91.5)
History of IS
Deﬁnite 14 (29.2)
Probable 5 (10.4)
No 28 (58.3)
Age of IS onset in weeks (n=19) 5.68 (2.75)
S.D., Standard deviation; IQ, intellectual quotient ; ID, intellectual
disability; IS, infantile spasm.
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FIG. 1. IQ distribution (a) overall, and by the presence of (b) a history of probable infantile spasm (IS), (c) frontal lobe cortical
tuber (CT) and (d ) temporal lobe CT.
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whether IQs were signiﬁcantly diﬀerent between
those with purely unilateral involvement of
either of these lobes. When considering lobar
CT count as opposed to CT presence or ab-
sence, only temporal lobe CT count showed
a statistically signiﬁcant correlation with IQ
(Spearman’sr=x0.42, p=0.003). This relation-
ship was not found for frontal (p=0.074), par-
ietal (p=0.785) or occipital (p=0.264) lobe
CT number.
We also determined which of the CT variables
showing statistically signiﬁcant univariate as-
sociations with measures of intellectual function
remained signiﬁcant in a multivariate ordinal
regression analysis limited to using CT variables
as predictors. In a model containing total CT
count, and the presence of both frontal and
temporal CTs, frontal (regression coeﬃcient=
x2.43, p=0.019) and temporal (regression co-
eﬃcient=1.60, p=0.018) CTs remained signiﬁ-
cant, while total CT count did not show a
signiﬁcant contribution to this model (p=0.41).
Thus the most parsimonious model for CT
variables predictive of IQ (shown in Table 2a)
was one including only the presence of CTs in
frontal (regression coeﬃcient=2.15, p=0.03)
and temporal lobes (regression coeﬃcient=
x1.29, p=0.03), and explained 25.4% of the
variance in IQ (Nagelkerke pseudo R2).
Multivariate analyses combining CT variables
and IS as predictors
The results above demonstrated that, in uni-
variate analyses, a history of IS and the presence
of CTs in frontal and temporal lobes were as-
sociated with IQ. These three variables were
therefore entered into a multivariate analysis to
determine which of them would still show stat-
istically signiﬁcant independent contributions to
the prediction of IQ. When the probable pres-
ence of IS was added to the model containing
the aﬀectation status of both temporal and
frontal lobes (Table 2c), the total variance of
cognitive ability explained by the model in-
creased to 29.7% (Nagelkerke pseudo R2). In
this model IS status was not signiﬁcantly asso-
ciated with IQ (p=0.11), whereas it had shown a
strong association when used as a sole indepen-
dent variable (p=0.01) (Table 2b). Temporal
(p=0.05) and frontal (p=0.06) lobe aﬀectation
status, however, both remained at least mar-
ginally signiﬁcant in this model with three inde-
pendent variables.
DISCUSSION
This study demonstrated using univariate
analyses that a probable history of IS, total
cerebral CT number, temporal lobe CT number,
and CT presence in temporal and frontal lobes
were all signiﬁcantly associated with IQ. The
latter two of these factors remained signiﬁcantly
associated with IQ when controlling for total
cerebral CT count. Total CT count failed to
show a signiﬁcant association with IQ once the
presence of CTs in frontal and temporal lobes
was taken into account. There was no signiﬁcant
relationship, however, between age of seizure
onset and either CT number or IQ. Our multi-
variate analyses suggest that, of all the inde-
pendent variables showing a relationship with
IQ on univariate analyses, only temporal and
frontal lobe CT presence remain marginally
signiﬁcant when entered together, and this
model predicts close to 30% of the variance in
IQ. Importantly, their inclusion renders a his-
tory of probable IS insigniﬁcant.
Limitations
There are a number of potential limitations to
this study. First, there may be selection bias, in
that subjects represent a relatively more intel-
lectually disabled subset of a larger sample
recruited through two specialist regional clinics.
However, it is important to note that the
Table 2. Multivariate ordinal regression
models for IQ (n=47)
Predictor variables
Regression
coeﬃcient (S.E.)
Signiﬁcance
(p)
(a) CT predictors alone
CTs in temporal lobe x1.29 (0.58) 0.03
CTs in frontal lobe x2.15 (0.97) 0.03
Nagelkerke R2=0.25
(b) IS as a predictor
Probable IS x1.39 (0.56) 0.013
Nagelkerke R2=0.13
(c) CT and IS predictors
CTs in temporal lobe x1.16 (0.60) 0.05
CTs in frontal lobe x1.84 (0.99) 0.06
Probable IS x0.92 (0.58) 0.11
Nagelkerke pseudo R2=0.30
IQ, Intellectual quotient; S.E., standard error; CT, cortical tuber ;
IS, infantile spasm.
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resultant sample has rates of IS and ID that lie
in between those reported in the two most recent
epidemiological samples, where near-complete
ascertainment is most likely (Joinson et al. 2003;
Devlin et al. 2006). Moreover, selection bias
of this kind is unlikely to inﬂuence the inter-
relationships between CT, IS and ID.
Second, although information was gathered
using standardized techniques where possible,
not all MRI scans were acquired using the same
protocol ; however, this is at worst likely to in-
troduce random error rather than any system-
atic bias. In addition, we were not able to index
CT load using summated volumetric variables
(i.e. proportion of frontal lobe volume consist-
ing of CT tissue) as used by some groups (Ridler
et al. 2004). Cognitive assessments were con-
ducted by more than one rater, using a variety
of instruments as necessitated by the wide
ranges of age and intellectual ability in our
sample. Final classiﬁcation of subjects into IQ
‘bins’ was determined by a close review of all
relevant clinical information, and conducted
blind to seizure history or details of CT load.
Seizure history was gathered retrospectively,
although this was done blind to other clinical
information, so it is unlikely that subjects were
non-randomly misclassiﬁed on this variable
with respect to psychometric intelligence. We
did not, unfortunately, have data on medication
history, quality of seizure control, or full details
of seizure types other than IS.
The outcome of interest in our study was
limited to ID. ID is, however, only one of the
neurodevelopmental risks associated with TS.
Elevated rates of emotional and behavioural
problems are well recognized in TS, and known
to often present a signiﬁcant problem for carers
(Hunt, 1983). However, little is known regard-
ing the brain mechanisms that might underlie
the risk for psychopathology in TS. Findings
on how rates of psychopathology change with
ID are inconsistent (Raznahan et al. 2006). This
is likely to partly reﬂect the challenges ofmeasur-
ing psychopathology in the context of a complex
heterogeneous neurodevelopmental disorder.
Unfortunately, because of the manner in
which our sample was characterized, our study
was not able to examine the relationship be-
tween brain lesions in TS and psychopath-
ology. This represents a key area for future re-
search.
Comparison with existing TS research
The overall load and distribution of CTs found
in our sample are similar to those reported by
other groups (O’Callaghan et al. 2004; Ridler
et al. 2004), and conﬁrm that frontoparietal
lobes are most frequently aﬀected by CTs.
Our ﬁndings on univariate analyses are in
general consistent with previous reports of the
relationship between IS and IQ/developmental
status (Riikonen & Simell, 1990; Shepherd &
Stephenson, 1992; Hunt, 1993; Shepherd et al.
1995; Webb et al. 1996; Jozwiak et al. 1998;
Joinson et al. 2003; Humphrey et al. 2004;
O’Callaghan et al. 2004), and CT and IQ
(Roach et al. 1987; Shepherd et al. 1995;
Goodman et al. 1997; Weber et al. 2000; Bolton
et al. 2002; O’Callaghan et al. 2004). In keeping
with the work of other groups, almost all TS
subjects with ID had a history of epilepsy.
Despite ﬁnding strong associations between a
history of epilepsy and various aspects of CT
load, we failed to replicate the statistically sig-
niﬁcant relationship between IS and total CT
count as reported by O’Callaghan et al. (2004).
There are no obvious reasons why two such
comparable analyses should contradict each
other in two groups of comparable size, other
than sample diﬀerences reﬂected by the two
subject groups having diﬀering levels of ID.
Other studies have demonstrated an association
between epilepsy and CTs using a variety of
scales for measuring CT number. Importantly,
none of these studies used lifetime history of IS
as their seizure variable of interest, but used
other indices such as seizure type at seizure on-
set (Shepherd et al. 1995), and quality of seizure
control (Roach et al. 1987). Taken together, the
ﬁndings so far generate a general pattern sug-
gesting that epilepsy ‘goes with’ CTs in TS.
Clearly, there is still more work to be done in
picking this relationship apart.
In keeping with some studies (Jozwiak et al.
1998; Goh et al. 2005), we did not ﬁnd an as-
sociation between age of IS onset and ID in our
sample, although this has been reported pre-
viously (Shepherd & Stephenson, 1992; Webb
et al. 1996; Joinson et al. 2003). This incon-
sistency may reﬂect the variety of scales used to
measure age of seizure onset, and whether or
not seizure type (i.e. IS or other) was controlled
for during analyses. Those studies where age of
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seizure onset was measured as a continuous
variable, or seizure type was included in analy-
ses, failed to ﬁnd any association between age of
seizure onset and IQ.
Our ﬁndings on multivariate analysis diﬀer
from those of the only other study using a
broadly comparable approach (O’Callaghan
et al. 2004). The ﬁndings of O’Callaghan et al.
suggest that total CT number and IS status
in combination predict IQ in TS. When CT
measures were considered regionally (without
controlling for total CT number), only occipital
lobe CT number was found to predict IQ.
Results that allow one to consider the degree to
which IS status and regional CT load can pre-
dict IQ in TS are not, however, presented.
Towards a model for ID in TS
In attempting to build aetiological models it is
important to distinguish statistically associated
factors, risk markers and risk factors. The ﬁrst
identiﬁes a mathematical phenomenon, the se-
cond identiﬁes a proxy measure and the third
refers to a factor shown to be directly causal.
For example, CTs may lead directly to an in-
creased risk of ID but could also act as markers
of other aspects of disease severity (e.g. par-
enchymal abnormalities, anti-epileptic poly-
pharmacy necessitated by seizure treatment
resistance) that in turn sit on the causal pathway
to ID. There is already, for example, evidence in
TS that more radiographically subtle par-
enchymal brain abnormalities can be associated
with neuropsychological outcome (Ridler et al.
2007). Similarly, while IS may lead directly to
ID in TS (e.g. through disruption of connec-
tivity in developing neural systems), they might
act as a marker for a causal risk factor with
which they in turn are associated, such as sub-
clinical electrophysiological dysregulation.
What evidence is there to support one of the
deductions prompted by our results, that fron-
totemporal involvement in TS might increase
risk for ID in TS? Such studies as are available
in TS that might address this issue have already
been reviewed. If it is assumed, however, that
regional specialization of the cerebral cortex in
TS is broadly similar to that which emerges
during normal brain development, then one can
look to the extensive research that studies the
neural underpinnings of psychometric intelli-
gence in neurotypical individuals for answers.
Clearly, psychometric intelligence is not a
unitary concept, and superﬁcially at least, dif-
ferent tests appear to tap diﬀerent cognitive
skills. There have long been well-recognized
positive correlations among scores on diﬀering
tests of intelligence at a group level. The general
statistical factor accounting for such corre-
lations, ‘g ’, was ﬁrst described by Spearman
(1927). There is great controversy as to the uni-
tary nature of g, how it relates to other models
of intelligence, if it does in fact represent a bio-
logically reducible entity, and if so, what the
relevant brain systems might be (Duncan, 2005;
Blair, 2006). This controversy has a bearing on
our discussion. If g is not just statistically but
also biologically meaningful, then it might be
expected that the brain systems subserving tasks
that strongly tap g would be of great importance
in determining psychometric intelligence. Were
such systems to be widely distributed across
the brain, then in a disorder such as TS, strong
regional eﬀects in associations between brain
lesions and IQ would be less likely. Alterna-
tively, were such systems to be relatively local-
ized, brain involvement in TS would be expected
to have the regionally speciﬁc association with
IQ described in our study.
Structural MRI studies support the second
model in both adulthood (Thompson et al.
2001; Haier et al. 2004, 2005) and childhood
(Shaw et al. 2006). Although whole grey matter
volume and a variety of regionally speciﬁc grey
matter volumes have been positively correlated
with IQ cross-sectionally, it is frontal lobe grey
matter volume that emerges as the structural
brain measure most consistently associated with
intelligence. Intriguingly, ﬁndings from twin
studies suggest that cortical areas showing most
volumetric heritability are the same as those
showing the strongest correlations with intelli-
gence, and that there is marked overlap in the
genetic factors inﬂuencing these two traits
(Toga & Thompson, 2005). Longitudinal data
(Shaw et al. 2006) suggest that the frontal lobes
are disproportionately associated with intel-
ligence across childhood and adolescence, and
that diﬀerences in the temporal proﬁle of dy-
namic changes in cortical thickness in such re-
gions distinguish individuals of supra-normal
intelligence from others. Functional MRI has
also been used to investigate brain activation
patterns during psychometric testing, although
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the wide variety of paradigms used makes it
diﬃcult to draw broad conclusions. However, in
an elegant study, Duncan et al. (2000) used a
battery of tasks with high g contrast to demon-
strate that the lateral frontal regions are a key
component of the brain systems underlying
general intelligence.
Thus, the broader neuroscientiﬁc literature
just reviewed supports our ﬁnding that involve-
ment of frontotemporal regions is predictive
of reduced IQ in TS. The majority of such
work relates to the brain in adulthood, however.
TS is a neurodevelopmental disorder, with
recent studies identifying subtle parenchymal
abnormalities that suggest disordered early
neuronal migration. The non-deterministic
model for cortical regionalization of cognitive
functions encapsulated in the theory of ‘ inter-
active specialisation’ (Johnson et al. 2002)
explicitly allows for the emergence of atypical
patterns of regional specialization in develop-
mental disorders of the brain. It is of par-
ticular interest, therefore, that those cortical
regions underpinning psychometric intelli-
gence in neurotypical adults are the same as
those where CT presence is associated with
ID among youth with TS. This implies that
the plasticity that might otherwise ‘work
around’ early lesions of the frontal lobes is lim-
ited in TS.
What might be the mechanisms by which CT
presence in frontotemporal regions interferes
with performance in tests of intelligence? The
distinction between risk markers and risk fac-
tors highlighted above is of relevance to this
question. CTs may be direct risk factors for ID
through mechanisms such as reduction of intact
grey matter volume, or interference with con-
nectivity between key brain regions. Alterna-
tively, frontotemporal CT presence could
simply be a marker for other causal aspects of
disease severity. One such scenario is that CTs
may act as epileptogenic foci (Guerreiro et al.
1998), a model already proposed in relation to
the biological determinants of autism in TS
(Bolton et al. 2002). Alternatively, CTs may in-
dex more subtle parenchymal neuroanatomical
disturbances.
Similar consideration apply to the role of
epilepsy and IS in ID. Our study supports
the impression that ID is hardly ever observed
in TS without epilepsy. This suggests that
with respect to IQ, either epilepsy is acting as a
non-causal marker of disease severity (in
which case the threshold for liability to epilepsy
in TS would be lower than the threshold for
liability to ID) or epilepsy may causally con-
tribute to reduction in IQ. As our sample only
included four individuals without epilepsy, we
did not have the power to distinguish between
these two hypotheses. Turning to IS, the strong
association shown between IS and ID in uni-
variate analysis disappeared when CT measures
were accounted for, possibly indicating that
IS may not be a direct risk factor for ID in TS.
This conclusion runs against many studies that
point to the developmentally noxious eﬀects
of brain disorders associated with seizures in
general (Rutter et al. 1976; Rodenburg et al.
2005; Vingerhoets, 2006), but on closer analysis
evidence directly linking the seizures in such
disorders to any ID is not so strong. The classi-
cal confounders in studies of behavioural out-
comes in epilepsy are the eﬀects of underlying
brain pathology, anti-epileptic medication, and
the psychosocial impact of disease on develop-
ment. These confounders also complicate at-
tempts to determine epilepsy/IS–behaviour links
in TS.
Clearly, much work needs to be done in
building robust models of the brain mechanisms
for ID in TS. Prospective study of larger sam-
ples with additional measures such as electro-
encephalography (EEG) recordings, composite
indices of seizure severity, and wider neuro-
psychological assessment are needed. In such
studies it will also be important to quantify the
neurostructural impact of TS in a manner that
recognizes the more recently described subtle
neuromigrational lesions.
Building a better understanding of brain–
cognition links in TS will bring us closer to
ameliorating the neurodevelopmental impact of
this disorder. It will also be of great importance
to the study of developmental psychology, and
developmental psychopathology more gener-
ally.
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